Set Your Sights On Fate Therapeutics Inc (NASDAQ: FATE)’S Upside Potential

Fate Therapeutics Inc (FATE) concluded trading on Thursday at a closing price of $7.08, with 2.91 million shares of worth about $20.58 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 153.76% during that period and on Thursday the price saw a gain of […]

Analyst Expect Big Moves From Fate Therapeutics Inc (NASDAQ: FATE)

Redmile Group LLC recently announced the acquisition of new stake in Fate Therapeutics Inc (NASDAQ:FATE). The institutional investor has increased its shareholding in the Healthcare company by 0.43% to 13.18 million shares with purchase of 55961.0 shares. This fresh investment now brings its stake to 13.37% valued currently at $49.29 million. In addition, BlackRock Fund […]

Fate Therapeutics Inc (NASDAQ: FATE) Not A Good Play Anymore?

Redmile Group LLC has recently announced that it has increased stake in Fate Therapeutics Inc (NASDAQ:FATE) by 0.43%. After grabbing 13.18 million shares, the institutional investor is now in possession of 55961.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 13.37% having worth around $49.29 million. Moreover, BlackRock […]

Fate Therapeutics Inc (FATE): Insights At A Glance

Redmile Group LLC has recently announced that it has increased stake in Fate Therapeutics Inc (NASDAQ:FATE) by 0.43%. After grabbing 13.18 million shares, the institutional investor is now in possession of 55961.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 13.37% having worth around $32.82 million. Moreover, BlackRock […]